OBJECTIVE: The aim of the study was to evaluate the variant (rs2910829) of the PDE4D gene in relation to its influence on biochemical, anthropometric and physiological parameters in patients with coronary artery disease and healthy subjects of the Eastern Slovak population. METHODS: The male group consisted of 72 individuals and the female group consisted of 132 individuals. On the basis of clinical screening the subjects were divided into two groups - with ischaemic heart disease and control group. Genomic DNA was isolated from peripheral blood using a commercial NucleoSpin® Blood Machenery-Nagel kit. Molecular genetic analysis of the polymorphism under study was performed using the StepOne™ Real-Time PCR System instrument. The lipid profile markers TC, HDL, LDL, TG were measured by Cobas Integra 400 plus biochemical analyser, and systolic and diastolic blood pressure using a digital blood pressure monitor. Among anthropometric parameters, body height and weight, waist and hip circumference were measured and BMI and WHR indices were calculated. RESULTS: A statistically significant (p = 0.018) possible association between the mutant T allele and ischaemic heart disease was found in men. In women, we found a statistically significant difference in the systolic (p = 0.013) and diastolic blood parameters (p = 0.005) in the CC genotype. In the group of women, we found statistically significant differences in all observed anthropometric parameters and in LDL and TC markers. In the group of men divided on the basis of BMI, statistical significance was found in systolic blood pressure (p = 0.028). In the group of women with ischaemic heart disease, we found a negative correlation between BMI and HDL. CONCLUSION: The study contributes to new findings of the representation of genotypes and alleles of the rs2910829 PDE4D gene polymorphism in the Slovak population. This is a pilot study. Interactions between genotype and observed anthropometric, physiological and biochemical markers were confirmed.

AGEL Hospital Kosice Saca Slovak Republic

Department of Biology Faculty of Humanities and Natural Sciences University of Presov Presov Slovak Republic

Department of Natural Sciences and Technological Disciplines Faculty of Education University of Presov Presov Slovak Republic

Department of Physics Mathematics and Technologies Faculty of Humanities and Natural Sciences University of Presov Presov Slovak Republic

Zobrazit více v PubMed

Jensen RV, Hjortbak MV, Bøtker HE. Ischemic heart disease: an update. Semin Nucl Med. 2020 Mar 2;50(3):195-207. PubMed DOI

Severino P, D'Amato A, Pucci M, Infusino F, Adamo F, Birtolo LI, et al. Ischemic heart disease pathophysiology paradigms overview: from plaque activation to microvascular dysfunction. Int J Mol Sci. 2020 Oct 30;21(21):8118. doi: 10.3390/ijms21218118. PubMed DOI

Hartley A, Marshall DC, Salciccioli JD, Sikkel MB, Maruthappu M, Shalhoub J. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009. Circulation. 2016 May 17;133(20):1916-26. PubMed DOI

Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi SKBM, AlKatheeri R, et al. Global epidemiology of ischemic heart disease: results from the Global Burden of Disease Study. Cureus. 2020 Jul 23;12(7):e9349. doi: 10.7759/cureus.9349. PubMed DOI

Wang F, Yu Y, Mubarik S, Zhang Y, Liu X, Cheng Y, et al. Global burden of ischemic heart disease and attributable risk factors, 1990-2017: a secondary analysis based on the Global Burden of Disease Study 2017. Clin Epidemiol. 2021 Sep 21;13:859-70. PubMed DOI

Yan L, Li K, Zhang W, Shen C, Ma L, Sun Y. The relationship between phosphodiesterase 4D gene polymorphism and coronary heart disease. Cell Mol Biol (Noisy-le-grand). 2022 Feb 27;67(6):26-32. DOI

Yue X, Lixia L, Yan H, Zhang P, Gui Y, Song J. Association between PDE4D polymorphism and ischemic stroke in young population. Saudi Med J. 2019 Apr 9;26(5):1023-26. PubMed DOI

Balashkevich N, Kazymov M, Syzdykbayev M, Adylova A. Molecular basis of acute coronary syndrome. J Res Med Sci. 2022 May 30;27:40. doi: 10.4103/jrms.jrms_695_21. PubMed DOI

Wang H, Gaur U, Xiao J, Xu B, Xu J, Zheng W. Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke. Int J Biol Sci. 2018 Oct 3;14(12):1745-54. DOI

Worrall BB, Mychaleckyj JC. PDE4D and stroke: a real advance or a case of the Emperor's new clothes? Stroke. 2006 Aug;37(8):1955-7. DOI

Laslett LJ, Alagona P, Clark BA, Drozda JP, Saldivar F, Wilson SR, et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues a report from the American College of Cardiology. J Am Coll Cardiol. 2012;60(25 Suppl):S1-49. PubMed DOI

Townsend N, Nichols M, Scarborough P, Rayner M. Cardiovascular disease in Europe - Epidemiological update 2015. Eur Heart J. 2015 Oct 21;36(40):2696-705. DOI

Kurtoğlu Gümüşel H, Çatakoğlu AB, Yildirimtürk Ö, Yurdakul S, Helvacioğlu F, Ziyrek M, et al. Relationship between endothelial dysfunction and cardiovascular risk factors and the extent and severity of coronary artery disease. Turk Kardiyol Dern Ars. 2014;42(5):435-43.

Rodríguez-Pérez JM, Posadas-Sánchez R, Blachman-Braun R, Vargas-Alarcón G, Posadas-Romero C, García-Flores E, et al. A haplotype of the phosphodiesterase 4D (PDE4D) gene is associated with myocardial infarction and with cardiometabolic parameters: the GEA study. EXCLI J. 2018 Dec 19;17:1182-90.

Milton AG, Aykanat VM, Hamilton-Bruce MA, Nezic M, Jannes J, Koblar SA. Association of the phosphodiesterase 4D (PDE4D) gene and cardioembolic stroke in an Australian cohort. Int J Stroke. 2011 Dec;6(6):480-6. PubMed DOI

Sinha E, Meitei SY, Garg PR, Saraswathy KN. PDE4D gene polymorphisms and coronary heart disease: a case-control study in a north Indian population. J Clin Lab Anal. 2013 Jul;27(4):297-300. PubMed DOI

Wang X, Sun Z, Zhang Y, Tian X, Li Q, Luo J. Impact of the PDE4D gene polymorphism and additional SNP-SNP and gene-smoking interaction on ischemic stroke risk in Chinese Han population. Neurol Res. 2017 Apr;39(4):351-6. PubMed DOI

Woo D, Kaushal R, Kissela B, Sekar P, Wolujeicz M, Pal P, et al. Association of phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke. 2006 Feb;37(2):371-6. DOI

Ma J, Sun Q, Zhang X, Du H. Correlation between the single nucleotide polymorphisms of the human phosphodiesterase 4D gene and the risk of cerebral infarction in the Uygur and Han ethnic groups of Xinjiang, China. Exp Ther Med. 2014 Jan;7(1):155-60. PubMed DOI

Qiao W, Zhang X, Kan B, Vuong AM, Xue S, Zhang Y, et al. Hypertension, BMI, and cardiovascular and cerebrovascular diseases. Open Med (Wars). 2021 Jan 21;16(1):149-55. PubMed DOI

Quesada O, Lauzon M, Buttle R, Wei J, Suppogu N, Kelsey SF, et al. Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women? Eur J Prev Cardiol. 2022;29(12):1608-14. PubMed DOI

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097-105. PubMed DOI

Wang ZJ, Zhou YJ, Galper BZ, Gao F, Yeh RW, Mauri L. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart. 2015 Oct;101(20):1631-8. PubMed DOI

Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009 May 26;53(21):1925-32. PubMed DOI

Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013 Apr;1(2):93-102. DOI

Soujanya KV, Jayadeep AP. Obesity-associated biochemical markers of inflammation and the role of grain phytochemicals. J Food Biochem. 2022 Sep;46(9):e14257. doi: 10.1111/jfbc.14257. PubMed DOI

Csige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, Harangi M, et al. The impact of obesity on the cardiovascular system. J Diabetes Res. 2018 Nov 4;218:3407306. doi: 10.1155/2018/3407306. PubMed DOI

Garcez MR, Pereira JL, Fontanelli MM, Marchioni DML, Fisberg RM. Prevalence of dyslipidemia according to the nutritional status in a Representative Sample of São Paulo. Arq Bras Cardiol. 2014 Dec;103(6):476-84. PubMed DOI

Rocha FL, Menezes TN, Melo RLP, Pedraza DF. Correlation between indicators of abdominal obesity and serum lipids in the elderly. Rev Assoc Med Bras. 2013;59(1):48-55. DOI